Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

I-crei meganuclease variants with modified specificity, method of preparation and uses thereof

a meganuclease and specificity technology, applied in the field of i-crei meganuclease variants with modified specificity, method of preparation and use thereof, can solve the problems of low efficiency, limited technology, and inability to have a natural meganuclease cleaving a gene of interes

Inactive Publication Date: 2011-03-24
CELLECTIS SA
View PDF0 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0046]R3 represents a nucleic acid triplet corresponding to said positions −5 to −3, selected among g, t, c and a, except the following triplets : gtc, gcc, gtg, gtt and gct; therefore said nucleic acid triplet is preferably selected among the following triplets: ggg, gga, ggt, ggc, gag, gaa, gat, gac, gta, gcg, gca, tgg, tga, tgt, tgc, tag, taa, tat, tac, ttg, tta, ttt, ttc, tcg, tca, tct,

Problems solved by technology

Homologous gene targeting is the most precise way to stably modify a chromosomal locus in living cells, but its low efficiency remains a major drawback.
However, this technology is still limited by the low number of potential natural target sites for meganucleases: although several hundreds of natural homing endonucleases have been identified (Belfort and Roberts, 1997; Chevalier and Stoddard, 2001), the probability to have a natural meganuclease cleaving a gene of interest is extremely low.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • I-crei meganuclease variants with modified specificity, method of preparation and uses thereof
  • I-crei meganuclease variants with modified specificity, method of preparation and uses thereof
  • I-crei meganuclease variants with modified specificity, method of preparation and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

Screening for New Functional Endonucleases

[0141]The method for producing meganuclease variants and the assays based on cleavage-induced recombination in mammal or yeast cells, which are used for screening variants with altered specificity, are described in the International PCT Application WO 2004 / 067736. These assays result in a functional LacZ reporter gene which can be monitored by standard methods (FIG. 3a).

A) Material and Methods

a) Construction of Mutant Libraries

[0142]I-CreI wt and I-CreI D75N (or I-CreI N75) open reading frames (SEQ ID NO:69, FIG. 4A) were synthesized, as described previously (Epinat et al., N.A.R., 2003, 31, 2952-2962). Mutation D75N was introduced by replacing codon 75 with aac. The diversity of the meganuclease library was generated by PCR using degenerate primers from Sigma harboring codon VVK (18 codons, amino acids ADEGHKNPQRST) at position 44, 68 and 70 which interact directly with the bases at positions 3 to 5, and as DNA template, the I-CreI D75N gen...

example 2

I-CreI Meganuclease Variants with Different Cleavage Profiles

[0153]The validated clones from example 1 showed very diverse patterns. Some of these new profiles shared some similarity with the initial scaffold whereas many others were totally different. Various examples of profiles, including wild-type I-CreI and I-CreI N75, are shown in FIGS. 8 and 9a. The overall results (only for the 292 variants with modified specificity) are summarized in FIG. 7.

[0154]Homing endonucleases can usually accommodate some degeneracy in their target sequences, and one of our first findings was that the original I-CreI protein itself cleaves seven different targets in yeast. Many of our mutants followed this rule as well, with the number of cleaved sequences ranging from 1 to 21 with an average of 5.0 sequences cleaved (standard deviation=3.6). Interestingly, in 50 mutants (14%), specificity was altered so that they cleaved exactly one target. 37 (11%) cleaved 2 targets, 61 (17%) cleaved 3 targets and ...

example 3

Novel Meganucleases Can Cleave Novel Targets While Keeping High Activity and Narrow Specificity

A) Material and Methods

a) Construction of Target Clones

[0156]The 64 palindromic targets were cloned into pGEM-T Easy (PROMEGA), as described in example 1. Next, a 400 by PvuII fragment was excised and cloned into the mammalian vector pcDNA3.1-LACURAZ-AURA, described previously (Epinat et al., precited). The 75 hybrid targets sequences were cloned as follows: oligonucleotides were designed that contained two different half sites of each mutant palindrome (PROLIGO).

b) Re-Cloning of Primary Hits

[0157]The open reading frame (ORF) of positive clones identified during the primary screening in yeast was recloned in: (i) a CHO gateway expression vector pCDNA6.2, following the instructions of the supplier (INVITROGEN), and ii) a pET 24d(+) vector from NOVAGEN Resulting clones were verified by sequencing (MILLEGEN).

c) Mammalian Cells Assay

[0158]CHO-K1 cell line from the American Type Culture Collect...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Login to View More

Abstract

Method of preparing I-CreI meganuclease variants having a modified cleavage specificity, variants obtainable by said method and their applications either for cleaving new DNA target or for genetic engineering and genome engineering for non-therapeutic purposes. Nucleic acids encoding said variants, expression cassettes comprising said nucleic acids, vectors comprising said expression cassettes, cells or organisms, plants or animals except humans, transformed by said vectors.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS [0001]The present application is a continuation of U.S. Ser. No. 11 / 908,798, filed on Sep. 17, 2007, which is a National Stage (371) of PCT / IB06 / 01203, filed on Mar. 15, 2006, which claims priority to PCT / IB05 / 00981, filed on Mar. 15, 2005, and PCT / IB05 / 03083, filed on Sep. 19, 2005.BACKGROUND OF THE INVENTION[0002]The present invention relates to a method of preparing I-CreI meganuclease variants having a modified cleavage specificity. The invention relates also to the I-CreI meganuclease variants obtainable by said method and to their applications either for cleaving new DNA target or for genetic engineering and genome engineering fornon-therapeutic purposes.[0003]The invention also relates to nucleic acids encoding said variants, to expression cassettes comprising said nucleic acids, to vectors comprising said expression cassettes, to cells or organisms, plants or animals except humans, transformed by said vectors.[0004]Meganucleases are se...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A01K67/027C12N9/16C07H21/00C12N15/63C12N5/10A01H5/00C12N15/66A61K31/7088
CPCA61K38/00C12N9/22A61K48/00A61P31/00A61P31/12A61P43/00
Inventor DUCHATEAU, PHILIPPEPAQUES, FREDERIC
Owner CELLECTIS SA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com